145 related articles for article (PubMed ID: 3279206)
1. New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site.
Luly JR; Bolis G; BaMaung N; Soderquist J; Dellaria JF; Stein H; Cohen J; Perun TJ; Greer J; Plattner JJ
J Med Chem; 1988 Mar; 31(3):532-9. PubMed ID: 3279206
[TBL] [Abstract][Full Text] [Related]
2. New inhibitors of human renin that contain novel Leu-Val replacements.
Luly JR; Yi N; Soderquist J; Stein H; Cohen J; Perun TJ; Plattner JJ
J Med Chem; 1987 Sep; 30(9):1609-16. PubMed ID: 3305946
[TBL] [Abstract][Full Text] [Related]
3. Design, structure-activity, and molecular modeling studies of potent renin inhibitory peptides having N-terminal Nin-For-Trp (Ftr): angiotensinogen congeners modified by P1-P1' Phe-Phe, Sta, Leu psi[CH(OH)CH2]Val or leu psi[CH2NH]Val substitutions.
Sawyer TK; Pals DT; Mao B; Staples DJ; de Vaux AE; Maggiora LL; Affholter JA; Kati W; Duchamp D; Hester JB
J Med Chem; 1988 Jan; 31(1):18-30. PubMed ID: 3275777
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and renin inhibitory activity of angiotensinogen analogues having dehydrostatine, Leu psi [CH2S]Val, or Leu psi [CH2SO]Val at the P1-P1' cleavage site.
Smith CW; Saneii HH; Sawyer TK; Pals DT; Scahill TA; Kamdar BV; Lawson JA
J Med Chem; 1988 Jul; 31(7):1377-82. PubMed ID: 3290486
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibitors. Dipeptide analogues of angiotensinogen utilizing a dihydroxyethylene transition-state mimic at the scissile bond to impart greater inhibitory potency.
Luly JR; BaMaung N; Soderquist J; Fung AK; Stein H; Kleinert HD; Marcotte PA; Egan DA; Bopp B; Merits I
J Med Chem; 1988 Dec; 31(12):2264-76. PubMed ID: 3143009
[TBL] [Abstract][Full Text] [Related]
6. Renin inhibitors containing psi[CH2O] pseudopeptide inserts.
TenBrink RE; Pals DT; Harris DW; Johnson GA
J Med Chem; 1988 Mar; 31(3):671-7. PubMed ID: 3279210
[TBL] [Abstract][Full Text] [Related]
7. New inhibitors of renin that contain novel phosphostatine Leu-Val replacements.
Dellaria JF; Maki RG; Stein HH; Cohen J; Whittern D; Marsh K; Hoffman DJ; Plattner JJ; Perun TJ
J Med Chem; 1990 Feb; 33(2):534-42. PubMed ID: 2105396
[TBL] [Abstract][Full Text] [Related]
8. Renin inhibitors containing conformationally restricted P1-P1' dipeptide mimetics.
Williams PD; Perlow DS; Payne LS; Holloway MK; Siegl PK; Schorn TW; Lynch RJ; Doyle JJ; Strouse JF; Vlasuk GP
J Med Chem; 1991 Mar; 34(3):887-900. PubMed ID: 2002469
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and structure-activity relationships of human renin inhibitors designed from angiotensinogen transition state.
Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Etoh Y; Shimaoka I; Tsubaki A; Murakami M; Yamaguchi T
Chem Pharm Bull (Tokyo); 1990 Sep; 38(9):2487-93. PubMed ID: 2285979
[TBL] [Abstract][Full Text] [Related]
10. Potent in vivo inhibitors of rat renin: analogues of human and rat angiotensinogen sequences containing different classes of pseudodipeptides at the scissile site.
Sueiras-Diaz J; Jones DM; Szelke M; Leckie BJ; Beattie SR; Beattie C; Morton JJ
J Pept Res; 1997 Oct; 50(4):239-47. PubMed ID: 9352462
[TBL] [Abstract][Full Text] [Related]
11. Orally potent human renin inhibitors derived from angiotensinogen transition state: design, synthesis, and mode of interaction.
Iizuka K; Kamijo T; Harada H; Akahane K; Kubota T; Umeyama H; Ishida T; Kiso Y
J Med Chem; 1990 Oct; 33(10):2707-14. PubMed ID: 2120440
[TBL] [Abstract][Full Text] [Related]
12. Renin inhibitors based on novel dipeptide analogues. Incorporation of the dehydrohydroxyethylene isostere at the scissile bond.
Kempf DJ; de Lara E; Stein HH; Cohen J; Plattner JJ
J Med Chem; 1987 Nov; 30(11):1978-83. PubMed ID: 3312604
[TBL] [Abstract][Full Text] [Related]
13. New renin inhibitors containing novel analogues of statine.
Jones DM; Sueiras-Diaz J; Szelke M; Leckie BJ; Beattie SR; Morton J; Neidle S; Kuroda R
J Pept Res; 1997 Aug; 50(2):109-21. PubMed ID: 9273895
[TBL] [Abstract][Full Text] [Related]
14. Renin inhibitors. Synthesis of transition-state analogue inhibitors containing phosphorus acid derivatives at the scissile bond.
Allen MC; Fuhrer W; Tuck B; Wade R; Wood JM
J Med Chem; 1989 Jul; 32(7):1652-61. PubMed ID: 2661820
[TBL] [Abstract][Full Text] [Related]
15. Novel renin inhibitors containing derivatives of N-alkylleucyl-β-hydroxy-γ-amino acids.
Winiecka I; Jaworski P; Mazurek AP; Marszałek D; Goldnik A; Sokulski D
J Pept Sci; 2016 Feb; 22(2):106-15. PubMed ID: 26780837
[TBL] [Abstract][Full Text] [Related]
16. Renin inhibitors. I. Synthesis and structure-activity relationships of transition-state inhibitors containing homostatine analogues at the scissile bond.
Atsuumi S; Nakano M; Koike Y; Tanaka S; Matsuyama K; Nakano M; Morishima H
Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):364-70. PubMed ID: 1606632
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and evaluation of matrix metalloprotease inhibitors bearing cyclopropane-derived peptidomimetics as P1' and P2' replacements.
Reichelt A; Gaul C; Frey RR; Kennedy A; Martin SF
J Org Chem; 2002 Jun; 67(12):4062-75. PubMed ID: 12054939
[TBL] [Abstract][Full Text] [Related]
18. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
Raddatz P; Jonczyk A; Minck KO; Rippmann F; Schittenhelm C; Schmitges CJ
J Med Chem; 1992 Sep; 35(19):3525-36. PubMed ID: 1404233
[TBL] [Abstract][Full Text] [Related]
19. Design and synthesis of P2-P1'-linked macrocyclic human renin inhibitors.
Weber AE; Halgren TA; Doyle JJ; Lynch RJ; Siegl PK; Parsons WH; Greenlee WJ; Patchett AA
J Med Chem; 1991 Sep; 34(9):2692-701. PubMed ID: 1895289
[TBL] [Abstract][Full Text] [Related]
20. Novel renin inhibitors containing analogues of statine retro-inverted at the C-termini: specificity at the P2 histidine site.
Rosenberg SH; Plattner JJ; Woods KW; Stein HH; Marcotte PA; Cohen J; Perun TJ
J Med Chem; 1987 Jul; 30(7):1224-8. PubMed ID: 3298652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
